A
Anthony J. Windebank
Researcher at Mayo Clinic
Publications - 305
Citations - 19731
Anthony J. Windebank is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Dorsal root ganglion & Neurite. The author has an hindex of 71, co-authored 297 publications receiving 18052 citations. Previous affiliations of Anthony J. Windebank include University of Washington & University of Rochester.
Papers
More filters
Journal ArticleDOI
Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.
Herbert H. Schaumburg,Jerry G. Kaplan,Anthony J. Windebank,Nicholas A. Vick,Stephen Rasmus,David E Pleasure,Mark J. Brown +6 more
TL;DR: It is indicated that consumption of large doses of pyridoxine can cause sensory neuropathy or neuronopathy syndromes and that safe guidelines should be established for the use of this widely abused vitamin.
Journal ArticleDOI
Chemotherapy-induced neuropathy.
TL;DR: The neurologist managing the cancer patient who develops neuropathy must answer a series of important questions as follows: Are the symptoms due to peripheral neuropathy?
Journal ArticleDOI
Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes
Vanda A. Lennon,Thomas J. Kryzer,Guy E. Griesmann,Padraig E. O'Suilleabhain,Anthony J. Windebank,Andreas Woppmann,George P. Miljanich,Edward H. Lambert +7 more
TL;DR: The high frequency of P/Q-type calcium-channel antibodies found in patients with Lambert-Eaton syndrome implies that antibodies of this specificity have a role in the presynaptic pathophysiology of this disorder.
Journal ArticleDOI
A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery
TL;DR: This review critically discusses the advances in biomaterial-based NGCs, their limitations and where future improvements may be required.
Journal ArticleDOI
Chemotherapy-induced peripheral neuropathy: A current review
TL;DR: The approach to peripheral neuropathy in patients with cancer is discussed and the clinical phenotypes and pathomechanisms of specific neurotoxic chemotherapeutic agents are addressed.